Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 2026-10-14 | Erbez Georgia | See Remarks | Sale | 6,335 | $1.36 | $9K | 60.5K | View | |
| 2026-10-12 | 2026-10-14 | MOORE ALISON | Director & President and CEO | Sale | 6,335 | $1.36 | $9K | 244.2K | View | |
| 2026-06-11 | 2026-06-11 | De Vre Raymond | Director | Sale | 2,605 | $2.37 | $6K | 84.8K | View | |
| 2026-02-24 | 2026-02-25 | Lutz Stefan | Chief Scientific Officer | Sale | 5,862 | $1.13 | $7K | 130.4K | View | |
| 2026-02-06 | 2026-02-09 | Lutz Stefan | Chief Scientific Officer | Sale | 2,492 | $1.31 | $3K | 136.3K | View |
Informational purposes only, not investment advice.
tormere.com/research/CDXS · generated 2026-10-28
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-12 | Erbez Georgia | S | 6,335 | $8,619.4 |
| 2026-10-12 | MOORE ALISON | S | 6,335 | $8,619.4 |
| 2026-06-11 | De Vre Raymond | S | 2,605 | $6,173.85 |
| 2026-02-24 | Lutz Stefan | S | 5,862 | $6,641.06 |
| 2026-02-06 | Lutz Stefan | S | 2,492 | $3,257.29 |
Tormere — informational purposes only, not investment advice.